Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor.
D Wu, … , J Yang, W M Pardridge
D Wu, … , J Yang, W M Pardridge
Published October 1, 1997
Citation Information: J Clin Invest. 1997;100(7):1804-1812. https://doi.org/10.1172/JCI119708.
View: Text | PDF
Research Article Article has an altmetric score of 9

Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor.

  • Text
  • PDF
Abstract

Research Article

Authors

D Wu, J Yang, W M Pardridge

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1994 Total
Citations: 1 2 4 6 3 7 4 4 7 2 6 5 7 5 5 9 4 8 3 4 1 2 3 3 5 7 1 1 1 120
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (120)

Title and authors Publication Year
A peptide-neurotensin conjugate that crosses the blood-brain barrier induces pharmacological hypothermia associated with anticonvulsant, neuroprotective, and anti-inflammatory properties following status epilepticus in mice
Ferhat L, Soussi R, Masse M, Kyriatzis G, Girard S, Gassiot F, Gaudin N, Laurencin M, Bernard A, Bôle A, Ferracci G, Smirnova M, Roman F, Dive V, Cisternino S, Temsamani J, David M, Lécorché P, Jacquot G, Khrestchatisky M
eLife 2025
Advances in Intrathecal Nanoparticle Delivery: Targeting the Blood–Cerebrospinal Fluid Barrier for Enhanced CNS Drug Delivery
Madadi AK, Sohn MJ
Pharmaceuticals 2024
Insulin-inspired hippocampal neuron–targeting technology for protein drug delivery
Kamei N, Ikeda K, Ohmoto Y, Fujisaki S, Shirata R, Maki M, Miyata M, Miyauchi Y, Nishiyama N, Yamada M, Ohigashi Y, Takeda-Morishita M
Proceedings of the National Academy of Sciences of the United States of America 2024
Nanoparticles for Drug and Gene Delivery in Pediatric Brain Tumors' Cancer Stem Cells: Current Knowledge and Future Perspectives.
Abballe L, Spinello Z, Antonacci C, Coppola L, Miele E, Catanzaro G, Miele E
Pharmaceutics 2023
Improving the Treatment Effect of Carotenoids on Alzheimer's Disease through Various Nano-Delivery Systems.
Su W, Xu W, Liu E, Su W, Polyakov NE
International journal of molecular sciences 2023
Nanoparticle Targeting with Antibodies in the Central Nervous System.
Lee JH, Chapman DV, Saltzman WM
2023
Enhancing Antibody Exposure in the Central Nervous System: Mechanisms of Uptake, Clearance, and Strategies for Improved Brain Delivery
Schwinghamer K, Siahaan TJ
Journal of nanotheranostics 2023
A Historical Review of Brain Drug Delivery
Pardridge WM
Pharmaceutics 2022
Drug Delivery Strategies to Overcome the Blood-Brain Barrier (BBB).
Helms HCC, Kristensen M, Saaby L, Fricker G, Brodin B
Handbook of experimental pharmacology 2022
Overcoming the blood-brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches.
Mitusova K, Peltek OO, Karpov TE, Muslimov AR, Zyuzin MV, Timin AS
Journal of nanobiotechnology 2022
IgG Fusion Proteins for Brain Delivery of Biologics via Blood-Brain Barrier Receptor-Mediated Transport.
Boado RJ
Pharmaceutics 2022
Selection of single domain anti-transferrin receptor antibodies for blood-brain barrier transcytosis using a neurotensin based assay and histological assessment of target engagement in a mouse model of Alzheimer's related amyloid-beta pathology.
Su S, Esparza TJ, Brody DL
PloS one 2022
Advances in Antibody-Based Therapeutics for Cerebral Ischemia
Sun JM, Yen TL, Jan JS, Mwale PF, Teng RD, Taliyan R, Hsieh CT, Yang CH
Pharmaceutics 2022
Mathematical Models of Blood-Brain Barrier Transport of Monoclonal Antibodies Targeting the Transferrin Receptor and the Insulin Receptor
WM Pardridge, T Chou
Pharmaceuticals (Basel, Switzerland) 2021
Highly Specific Blood-Brain Barrier Transmigrating Single-Domain Antibodies Selected by an In Vivo Phage Display Screening
SI Aguiar, JN Dias, AS André, ML Silva, D Martins, B Carrapiço, M Castanho, J Carriço, M Cavaco, MM Gaspar, RJ Nobre, LP de Almeida, S Oliveira, L Gano, JD Correia, CB rd, J Gonçalves, V Neves, F Aires-da-Silva
Pharmaceutics 2021
Evolving new-age strategies to transport therapeutics across the blood-brain-barrier
M Choudhari, S Hejmady, RN Saha, S Damle, G Singhvi, A Alexander, P Kesharwani, SK Dubey
International Journal of Pharmaceutics 2021
Bioinspired Biomaterials: Advances in Tissue Engineering and Regenerative Medicine
HJ Chun, RL Reis, A Motta, G Khang
2020
Brain Drug Delivery: Overcoming the Blood-brain Barrier to Treat Tauopathies
J Hanes, E Dobakova, P Majerova
Current pharmaceutical design 2020
Advances in Animal Health, Medicine and Production: A Research Portrait of the Centre for Interdisciplinary Research in Animal Health (CIISA), University of Lisbon, Portugal
AF Duarte, LL da Costa
2020
Novel Blood–Brain Barrier Shuttle Peptides Discovered through the Phage Display Method
P Majerova, J Hanes, D Olesova, J Sinsky, E Pilipcinec, A Kovac
Molecules (Basel, Switzerland) 2020
Treatment of Alzheimer’s Disease and Blood–Brain Barrier Drug Delivery
WM Pardridge
Pharmaceuticals (Basel, Switzerland) 2020
Novel cyclic peptides facilitating transcellular blood-brain barrier transport of macromolecules in vitro and in vivo
S Yamaguchi, S Ito, T Masuda, PO Couraud, S Ohtsuki
Journal of Controlled Release 2020
Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood–Brain Barrier Using Receptor-Mediated Transcytosis
T Tashima
CHEMICAL & PHARMACEUTICAL BULLETIN 2020
Strategies for Enhancing the Permeation of CNS-Active Drugs through the Blood-Brain Barrier: A Review
I Zeiadeh, A Najjar, R Karaman
Molecules (Basel, Switzerland) 2018
Use of Polyamidoamine Dendrimers in Brain Diseases
M Florendo, A Figacz, B Srinageshwar, A Sharma, D Swanson, G Dunbar, J Rossignol
Molecules (Basel, Switzerland) 2018
Recent progress of drug nanoformulations targeting to brain
AR Khan, X Yang, M Fu, G Zhai
Journal of Controlled Release 2018
Drug targeting strategies into the brain for treating neurological diseases
W Barnabas
Journal of Neuroscience Methods 2018
Neurotoxicity of Nanomaterials and Nanomedicine
Y Liu, Q He
Neurotoxicity of Nanomaterials and Nanomedicine 2017
Delivery of Biologics Across the Blood–Brain Barrier with Molecular Trojan Horse Technology
WM Pardridge
BioDrugs 2017
Self-assembled amphiphilic core-shell nanocarriers in line with the modern strategies for brain delivery
RS Elezaby, HA Gad, AA Metwally, AS Geneidi, GA Awad
Journal of Controlled Release 2017
Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements
NM Varghese, V Senthil, SK Saxena
Journal of Drug Targeting 2017
Antibody therapies in CNS diseases
PO Freskgård, E Urich
Neuropharmacology 2016
Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies
YJ Zuchero, X Chen, N Bien-Ly, D Bumbaca, RK Tong, X Gao, S Zhang, K Hoyte, W Luk, MA Huntley, L Phu, C Tan, D Kallop, RM Weimer, Y Lu, DS Kirkpatrick, JA Ernst, B Chih, MS Dennis, RJ Watts
Neuron 2016
Progress and perspectives on targeting nanoparticles for brain drug delivery
H Gao
Acta Pharmaceutica Sinica B 2016
Role of scavenger receptors in peptide-based delivery of plasmid DNA across a blood–brain barrier model
A Srimanee, J Regberg, M Hällbrink, O Vajragupta, Ü Langel
International Journal of Pharmaceutics 2016
Functionalized Solid-Sphere PEG- b -PCL Nanoparticles to Target Brain Capillary Endothelial Cells In Vitro
P Grossen, G Québatte, D Witzigmann, C Prescianotto-Baschong, LH Dieu, J Huwyler
Journal of Nanomaterials 2016
Can dendrimer-based nanoparticles fight neurodegenerative diseases? Current situation versus other established approaches
S Mignani, M Bryszewska, M Zablocka, B Klajnert-Maculewicz, J Cladera, D Shcharbin, JP Majoral
Progress in Polymer Science 2016
Gb3-binding lectins as potential carriers for transcellular drug delivery
SK Müller, I Wilhelm, T Schubert, K Zittlau, A Imberty, J Madl, T Eierhoff, R Thuenauer, W Römer
Expert Opinion on Drug Delivery 2016
RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies
M Malhotra, A Toulouse, BM Godinho, DJ Carthy, JF Cryan, CM O'Driscoll
Molecular BioSystems 2015
Biobetters
A Rosenberg, B Demeule
2015
Dendrimer Advances for the Central Nervous System Delivery of Therapeutics
L Xu, H Zhang, Y Wu
ACS Chemical Neuroscience 2014
Insulin Receptor Antibody-Sulfamidase Fusion Protein Penetrates the Primate Blood-Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type A Cells
RJ Boado, JZ Lu, EK Hui, WM Pardridge
Molecular Pharmaceutics 2014
Solid lipid nanoparticles with surface antibody for targeting the brain and inhibiting lymphatic phagocytosis
YC Kuo, CY Shih-Huang
Journal of the Taiwan Institute of Chemical Engineers 2014
Polymersomes conjugated to 83-14 monoclonal antibodies: Invitro targeting of brain capillary endothelial cells
LH Dieu, D Wu, CG Palivan, V Balasubramanian, J Huwyler
European Journal of Pharmaceutics and Biopharmaceutics 2014
Targeted delivery of protein and gene medicines through the blood-brain barrier
WM Pardridge
Clinical Pharmacology & Therapeutics 2014
Innovative Brain Tumor Therapy
G Caruso, L Merlo, M Caffo
Innovative Brain Tumor Therapy 2014
Which drug or drug delivery system can change clinical practice for brain tumor therapy?
T Siegal
Neuro-Oncology 2013
Developing Therapeutic Antibodies for Neurodegenerative Disease
YJ Yu, RJ Watts
Neurotherapeutics 2013
Brain-targeted polymeric nanoparticles: in vivo evidences of different routes of administration in rodents
G Tosi, B Ruozi, D Belletti, A Vilella, M Zoli, MA Vandelli, F Forni
Nanomedicine 2013
Microspheres and Microcapsules in Biotechnology: Design, Preparation and Applications
C Jiang, X Jiang, Y Liu, K Shao, R Huang
Microspheres and Microcapsules in Biotechnology: Design, Preparation and Applications 2013
Design of brain imaging agents for positron emission tomography: do large bioconjugates provide an opportunity for in vivo brain imaging?
R Schirrmacher, V Bernard-Gauthier, A Reader, JP Soucy, E Schirrmacher, B Wängler, C Wängler
Future Medicinal Chemistry 2013
Neurological disorders and therapeutics targeted to surmount the blood–brain barrier
JR Kanwar, B Sriramoju, RK Kanwar
International Journal of Nanomedicine 2012
CHEMICAL OPTIMIZATION OF NEW LIGANDS OF THE LOW-DENSITY LIPOPROTEIN RECEPTOR AS POTENTIAL VECTORS FOR CENTRAL NERVOUS SYSTEM TARGETING
malcor, payrot, david, faucon, abouzid, jacquot, N Floquet, debarbieux, rougon, martinez, khrestchatisky, vlieghe, V Lisowski
Journal of Medicinal Chemistry 2012
Liposomes and their applications in molecular imaging
M Silindir, S Erdoğan, AY Özer, S Maia
Journal of Drug Targeting 2012
In Vivo Biodistribution of Prion- and GM1-Targeted Polymersomes following Intravenous Administration in Mice
K Stojanov, JV Georgieva, RP Brinkhuis, JC van Hest, FP Rutjes, RA Dierckx, EF de Vries, IS Zuhorn
Molecular Pharmaceutics 2012
Imaging Amyloid Plaque in Alzheimer’s Disease Brain with a Biotinylated Aβ Peptide Radiopharmaceutical Conjugated to an IgG-Avidin Fusion Protein
RK Sumbria, RJ Boado, WM Pardridge
Bioconjugate Chemistry 2012
Nanotechnology in Health Care: State of the Art
G Tosi, B Ruozi, L Badiali, L Bondioli, D Belletti, F Forni, M Vandelli
Nanotechnology in Health Care: State of the Art 2012
Drug transport across the blood-brain barrier
WM Pardridge
Journal of Cerebral Blood Flow & Metabolism 2012
Schleuservermittelter Transport von Wirkstoffen ins Gehirn
M Malakoutikhah, M Teixidó, E Giralt
Angewandte Chemie 2011
Shuttle-Mediated Drug Delivery to the Brain
M Malakoutikhah, M Teixidó, E Giralt
Angewandte Chemie International Edition 2011
Nanotechnological advances for the delivery of CNS therapeutics
HL Wong, XY Wu, R Bendayan
Advanced Drug Delivery Reviews 2011
Modern Methods for Delivery of Drugs across the Blood–brain Barrier
Y Chen, L Liu
Advanced Drug Delivery Reviews 2011
Current Topics in Developmental Biology
JE Qualls, PJ Murray
Cancer and Development 2011
Pharmaceutical Sciences Encyclopedia
D Farkas, RI Shader, LL von Moltke, DJ Greenblatt
Pharmaceutical Sciences Encyclopedia 2010
Macromolecular drug transport into the brain using targeted therapy
J Lichota, T Skjørringe, LB Thomsen, T Moos
Journal of Neurochemistry 2010
The C2-streptavidin delivery system promotes the uptake of biotinylated molecules in macrophages and T-leukemia cells
J Fahrer, J Rieger, G Zandbergen, H Barth
Biological Chemistry 2010
Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing
CD Davis, UM Hanumegowda
Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing 2010
Targeted Delivery of Protein Drugs by Nanocarriers
R Solaro, F Chiellini, A Battisti
Materials 2010
Peptide- and Aptamer-Functionalized Nanovectors for Targeted Delivery of Therapeutics
TO Pangburn, MA Petersen, B Waybrant, MM Adil, E Kokkoli
Journal of Biomechanical Engineering 2009
Receptor-mediated therapeutic transport across the blood–brain barrier
YY Wang, PC Lui, JY Li
Immunotherapy 2009
Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals
M Bartholomä, J Valliant, KP Maresca, J Babich, J Zubieta
Chemical Communications 2009
Production of human  -hexosaminidase A with highly phosphorylated N-glycans by the overexpression of the Ogataea minuta MNN4 gene
H Akeboshi, Y Kasahara, D Tsuji, K Itoh, H Sakuraba, Y Chiba, Y Jigami
Glycobiology 2009
Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries
U Hülsermann, MM Hoffmann, U Massing, G Fricker
Journal of Drug Targeting 2009
Supramolecularassemblies for the active drug targeting to the brain
A Béduneau, Y Pellequer, A Lamprecht
Journal of drug delivery science and technology 2009
Drug Delivery to the Central Nervous System
KK Jain
2009
Genetically Engineered Clostridial C2 Toxin as a Novel Delivery System for Living Mammalian Cells
J Fahrer, R Plunien, U Binder, T Langer, H Seliger, H Barth
Bioconjugate Chemistry 2009
Getting into the Brain: Approaches to Enhance Brain Drug Delivery
MM Patel, BR Goyal, SV Bhadada, JS Bhatt, AF Amin
CNS Drugs 2009
Psychoneuroimmunology
F Tausk, I Elenkov, J Moynihan
Dermatologic Therapy 2008
Strategies to advance translational research into brain barriers
E Neuwelt, NJ Abbott, L Abrey, WA Banks, B Blakley, T Davis, B Engelhardt, P Grammas, M Nedergaard, J Nutt, W Pardridge, GA Rosenberg, Q Smith, LR Drewes
The Lancet Neurology 2008
Antibody-Mediated Targeting of siRNA via the Human Insulin Receptor Using Avidin−Biotin Technology
CF Xia, RJ Boado, WM Pardridge
Molecular Pharmaceutics 2008
Synthesis and Screening of a Library of Re/Tc-Based Amyloid Probes Derived from β-Breaker Peptides
KA Stephenson, LC Reid, J Zubieta, JW Babich, MP Kung, HF Kung, JF Valliant
Bioconjugate Chemistry 2008
Strategies to Improve Drug Delivery Across the Blood-Brain Barrier:
AG de Boer, PJ Gaillard
Clinical Pharmacokinetics 2007
Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation
AR Jones, EV Shusta
Pharmaceutical Research 2007
Drug Targeting to the Brain
WM Pardridge
Pharmaceutical Research 2007
Nanotechnologies for the Life Sciences
C Leuschner
Nanotechnologies for the Life Sciences 2007
Strategies to Improve Drug Delivery Across the Blood-Brain Barrier
AG de Boer, PJ Gaillard
Clinical Pharmacokinetics 2007
Drug Targeting to the Brain
AG Boer, PJ Gaillard
Annual Review of Pharmacology and Toxicology 2007
Appetite and Body Weight
B Beck
Appetite and Body Weight 2007
Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology
CF Xia, Y Zhang, Y Zhang, RJ Boado, WM Pardridge
Pharmaceutical Research 2007
Humanization of anti-human insulin receptor antibody for drug targeting across the human blood–brain barrier
RJ Boado, Y Zhang, Y Zhang, WM Pardridge
Biotechnology and Bioengineering 2006
Pharmacokinetics and brain uptake of lactoferrin in rats
B Ji, J Maeda, M Higuchi, K Inoue, H Akita, H Harashima, T Suhara
Life Sciences 2006
Blood-Brain Barriers: From Ontogeny to Artificial Interfaces
R Dermietzel, DC Spray, M Nedergaard
2006
Neuroprotection in experimental stroke with targeted neurotrophins
D Wu
NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics 2005
Drug transport to brain with targeted liposomes
A Schnyder, J Huwyler
NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics 2005
Targeted delivery across the blood–brain barrier
PJ Gaillard, CC Visser, AG de Boer
Expert Opinion on Drug Delivery 2005
99mTc complex conjugated to insulin: CNS radio-pharmaceuticals design based on principles of blood-brain barrier transport vector
F Liu, C Fan, J Zhang, W Wang, B Liu
Chinese Science Bulletin 2005
Blood-Spinal Cord and Brain Barriers in Health and Disease
E Anderson, L Ryan, H Xiong, S Swindells, J Zheng, HE Gendelman
Blood-Spinal Cord and Brain Barriers in Health and Disease 2004
Aspartic Proteases Involved in Alzheimer's Disease
B Schmidt
ChemBioChem 2003
Peptide Transport and Delivery into the Central Nervous System
L Prokai, K Prokai-Tatrai
2003
Imaging brain amyloid of Alzheimer disease in vivo in transgenic mice with an Abeta peptide radiopharmaceutical
HJ Lee, Y Zhang, C Zhu, K Duff, WM Pardridge
Journal of Cerebral Blood Flow & Metabolism 2002
IMPY: an improved thioflavin-T derivative for in vivo labeling of β-amyloid plaques
MP Kung, C Hou, ZP Zhuang, B Zhang, D Skovronsky, JQ Trojanowski, VM Lee, HF Kung
Brain Research 2002
Membrane Transporters as Drug Targets
GL Amidon, W Sadée
2002
Vector-mediated drug delivery to the brain
J Temsamani, C Rousselle, AR Rees, JM Scherrmann
Expert Opinion on Biological Therapy 2001
Prodrug based optimal drug delivery via membrane transporter/receptor
C Yang, GS Tirucherai, AK Mitra
Expert Opinion on Biological Therapy 2001
Pharmacological in vitro evaluation of new substance P-cyclodextrin derivatives designed to drug targeting towards NK1-receptor bearing cells
C Péan, A Wijkhuisen, F Djedaïni-Pilard, J Fischer, S Doly, M Conrath, J Y Couraud, J Grassi, B Perly, C Créminon
Biochimica et Biophysica Acta 2001
Endogenous carriers and ligands in non-immunogenic site-specific drug delivery
SP Vyas, V Sihorkar
Advanced Drug Delivery Reviews 2000
The Blood-Brain Barrier and Drug Delivery to the CNS
A Tsuji
The Blood-Brain Barrier and Drug Delivery to the CNS 2000
Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor
MJ Coloma, HJ Lee, A Kurihara, EM Landaw, RJ Boado, SL Morrison, WM Pardridge
Pharmaceutical Research 2000
Drug Targeting to the Brain Using Avidin-Biotin Technology in the Mouse (Blood-Brain Barrier, Monoclonal Antibody, Transferrin Receptor, Alzheimer's Disease)
H Lee, W Pardridge
Journal of Drug Targeting 2000
Cerebral Amyloid Angiopathy in Alzheimer’s Disease and Related Disorders
MM Verbeek, RM de Waal, HV Vinters
2000
Blood–brain barrier permeability to small and large molecules
EM Cornford, S Hyman
Advanced Drug Delivery Reviews 1999
BARRIER MECHANISMS IN THE BRAIN, I. ADULT BRAIN
N Saunders, M Habgood, KM Dziegielewska
Clinical and Experimental Pharmacology and Physiology 1999
Potential applications of polymers in the delivery of drugs to the central nervous system
DW Miller, AV Kabanov
Colloids and Surfaces B: Biointerfaces 1999
Non-invasive drug delivery to the human brain using endogenous blood–brain barrier transport systems
WM Pardridge
Pharmaceutical Science & Technology Today 1999
Transfer of Some Carboxylic Acids in the Olfactory System Following Intranasal Administration
C Eriksson, U Bergman, A Franzén, M Sjöblom, EB Brittebo
Journal of Drug Targeting 1999
Model for the regulation of energy balance and adiposity by the central nervous system
MW Schwartz, DG Baskin, KJ Kaiyala, SC Woods
The American journal of clinical nutrition 1999
Cytokines, Stress, and Depression
R Dantzer, EE Wollman, R Yirmiya
1999
Signals That Regulate Food Intake and Energy Homeostasis
SC Woods, RJ Seeley, D Porte, MW Schwartz
Science 1998
Drug Delivery to the Brain
WM Pardridge
Journal of Cerebral Blood Flow & Metabolism 1997
Advances in Pharmacology
B Drenger, Y Ginosar, Y Gozal
Advances in Pharmacology 1994

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 42 patents
88 readers on Mendeley
See more details